DrugPatentWatch Database Preview
CLINICAL TRIALS PROFILE FOR CETROTIDE
Clinical Trials for Cetrotide
Trial ID | Title | Status | Sponsor | Phase | Summary |
---|---|---|---|---|---|
NCT00298025 | A Study to Compare the Safety and Efficacy of Cetrotide® 3 Milligram (mg) Versus Antagon™ in Women Undergoing Ovarian Stimulation | Completed | EMD Serono | Phase 4 | To demonstrate the comparative safety and efficacy of Cetrotide® 3 milligram (mg) and Antagon™ in the inhibition of a premature luteinizing hormone (LH) surge in women undergoing ovarian stimulation with recombinant human follicle stimulating hormone/human menopausal gonadotropin (r-hFSH/hMG) prior to assisted reproductive technology (ART) and utilizing oral contraceptives pill (OCP) for cycle programming. |
NCT00439829 | Synchronization of Follicle Wave Emergence and Ovarian Stimulation | Completed | Royal University Hospital Foundation | Phase 4 | The objective of the study is to elucidate the effect of synchronizing initiation of ovarian stimulation treatment with follicular wave emergence in poor responder patients undergoing IVF/ICSI and ET. We hypothesize that initiating treatment on day 1 versus day 4 of the cycle will increase the number of follicles recruited and oocytes retrieved. |
NCT00439829 | Synchronization of Follicle Wave Emergence and Ovarian Stimulation | Completed | University of Saskatchewan | Phase 4 | The objective of the study is to elucidate the effect of synchronizing initiation of ovarian stimulation treatment with follicular wave emergence in poor responder patients undergoing IVF/ICSI and ET. We hypothesize that initiating treatment on day 1 versus day 4 of the cycle will increase the number of follicles recruited and oocytes retrieved. |
Trial ID | Title | Status | Sponsor | Phase | Summary |
Clinical Trial Conditions for Cetrotide
Condition Name
Condition MeSH
Clinical Trial Locations for Cetrotide
Trials by Country
Clinical Trial Progress for Cetrotide
Clinical Trial Phase
Clinical Trial Sponsors for Cetrotide
Sponsor Name